Advancing vaccine development through green biotechnology

The diseases hepatitis B (HBV) and C (HCV) remain a significant health threat worldwide, causing approximately 1.3 million deaths each year.

Apolipoprotein A1 Infusions After Acute MI Disappoint in Phase III Trial

ATLANTA — Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other

April 9, 2024

Merck closes $10.8B deal with Prometheus

Merck closed its $10.8 billion acquisition of Prometheus Biosciences, setting the stage for the drugmaker’s pursuit of an immunology blockbuster. In a news release on

June 17, 2023

ECRI Unveils the Top 10 Patient Safety Concerns 2024

What You Should Know: – The ECRI Institute, a leader in patient safety research, has released its annual report highlighting the top ten patient safety

March 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.